Search
for

    Research

    5 / 1000+ results

      research Urinary steroids in women with androgenic alopecia

      16 citations , March 2000 in “Clinical Biochemistry”
      In this study, women with androgenic alopecia showed increased excretion of steroid metabolites and heightened 5α-reductase activity, suggesting these may contribute to the condition's hormonal abnormalities.

      research Urinary steroids in men with male-pattern alopecia

      13 citations , October 2002 in “Journal of Biochemical and Biophysical Methods”
      This study found that men with androgenic alopecia had significantly higher levels of certain urinary steroid metabolites, suggesting increased 5 alpha-reductase activity and possible mild hyperadrenal activity.

      research Treatment of canine Alopecia X with trilostane

      40 citations , October 2004 in “Veterinary Dermatology”
      In this study, trilostane treatment led to complete hair re-growth in 85% of Pomeranians and all miniature poodles with alopecia X within 4 to 8 weeks.

    Community Join

    3 / 1000+ results

      community Is this real chat? Finasteride -> fountain of youth and longevity drug?

       559 upvotes 1 year ago
      Finasteride is discussed as a hair loss treatment with benefits like reduced prostate enlargement and skin aging, but it is not seen as a "fountain of youth." Users report mixed experiences, including side effects like decreased libido and dry eyes.

      community You NEED this if You’re Taking Fin/Dut

      in Finasteride/Dutasteride 1 year ago
      DIM is suggested to help with estrogen metabolism for those on finasteride or dutasteride, potentially reversing side effects like fat gain and mood changes. Some users doubt its effectiveness, recommending lifestyle changes or consulting a doctor instead.

      community EU Shouldn't Ban Fin & Dut: PFS is NOT REAL.

       10 upvotes 1 year ago
      Finasteride and Dutasteride do not cause depression or "Post Finasteride Syndrome," with concerns often linked to the nocebo effect and preexisting mental health issues. The EU is unlikely to ban these drugs, but access may become more restricted due to ongoing debates.